| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 279 | 2026 | 618 | 61.560 |
Why?
|
| Endovascular Procedures | 296 | 2026 | 700 | 61.340 |
Why?
|
| Aortic Aneurysm, Thoracic | 182 | 2026 | 542 | 47.520 |
Why?
|
| Aortic Aneurysm, Abdominal | 154 | 2025 | 340 | 38.010 |
Why?
|
| Blood Vessel Prosthesis | 217 | 2026 | 441 | 36.780 |
Why?
|
| Stents | 188 | 2026 | 732 | 27.760 |
Why?
|
| Prosthesis Design | 176 | 2026 | 596 | 17.880 |
Why?
|
| Treatment Outcome | 337 | 2026 | 12393 | 9.270 |
Why?
|
| Aortic Aneurysm | 35 | 2025 | 188 | 9.050 |
Why?
|
| Postoperative Complications | 126 | 2026 | 2981 | 7.400 |
Why?
|
| Aorta, Thoracic | 32 | 2026 | 465 | 7.080 |
Why?
|
| Time Factors | 199 | 2025 | 6030 | 7.030 |
Why?
|
| Iliac Aneurysm | 22 | 2022 | 29 | 6.740 |
Why?
|
| Aged, 80 and over | 194 | 2026 | 6582 | 6.440 |
Why?
|
| Aortic Diseases | 22 | 2026 | 166 | 6.250 |
Why?
|
| Risk Factors | 209 | 2026 | 10374 | 5.800 |
Why?
|
| Aged | 280 | 2026 | 20078 | 5.640 |
Why?
|
| Renal Artery | 23 | 2024 | 67 | 5.400 |
Why?
|
| Endoleak | 33 | 2025 | 41 | 5.040 |
Why?
|
| Vascular Surgical Procedures | 40 | 2025 | 487 | 4.860 |
Why?
|
| Aortography | 56 | 2025 | 148 | 4.750 |
Why?
|
| Ischemia | 32 | 2022 | 347 | 4.380 |
Why?
|
| Aortic Rupture | 14 | 2024 | 103 | 4.210 |
Why?
|
| Computed Tomography Angiography | 36 | 2026 | 203 | 3.980 |
Why?
|
| Humans | 431 | 2026 | 126134 | 3.800 |
Why?
|
| Retrospective Studies | 205 | 2026 | 16831 | 3.720 |
Why?
|
| Mesenteric Vascular Occlusion | 17 | 2024 | 25 | 3.630 |
Why?
|
| Male | 297 | 2026 | 62225 | 3.490 |
Why?
|
| Angioplasty, Balloon | 18 | 2019 | 127 | 3.470 |
Why?
|
| Aneurysm | 16 | 2023 | 68 | 3.370 |
Why?
|
| Vascular Patency | 51 | 2025 | 175 | 3.160 |
Why?
|
| Prospective Studies | 53 | 2025 | 6178 | 3.100 |
Why?
|
| Female | 281 | 2026 | 68037 | 3.010 |
Why?
|
| Risk Assessment | 90 | 2025 | 3422 | 2.890 |
Why?
|
| Vascular Diseases | 17 | 2021 | 149 | 2.850 |
Why?
|
| Femoral Artery | 21 | 2025 | 139 | 2.850 |
Why?
|
| Mesenteric Ischemia | 19 | 2024 | 29 | 2.710 |
Why?
|
| Middle Aged | 174 | 2026 | 27402 | 2.620 |
Why?
|
| Spinal Cord Injuries | 10 | 2023 | 275 | 2.550 |
Why?
|
| Mesenteric Artery, Superior | 7 | 2023 | 31 | 2.510 |
Why?
|
| Aorta, Abdominal | 14 | 2022 | 96 | 2.350 |
Why?
|
| Patient Selection | 32 | 2024 | 698 | 2.210 |
Why?
|
| Saphenous Vein | 11 | 2024 | 46 | 2.180 |
Why?
|
| Iliac Artery | 15 | 2024 | 64 | 2.110 |
Why?
|
| Angioplasty | 14 | 2017 | 65 | 2.100 |
Why?
|
| Upper Extremity | 11 | 2025 | 52 | 2.090 |
Why?
|
| Ultrasonography, Doppler, Duplex | 10 | 2023 | 33 | 1.910 |
Why?
|
| Spinal Cord Ischemia | 11 | 2025 | 25 | 1.900 |
Why?
|
| Reoperation | 37 | 2025 | 791 | 1.850 |
Why?
|
| Radiation Exposure | 4 | 2025 | 42 | 1.830 |
Why?
|
| Popliteal Artery | 12 | 2021 | 33 | 1.800 |
Why?
|
| Tomography, X-Ray Computed | 47 | 2020 | 2012 | 1.780 |
Why?
|
| Quality of Life | 9 | 2025 | 2014 | 1.750 |
Why?
|
| Kidney | 15 | 2022 | 1262 | 1.710 |
Why?
|
| Graft Occlusion, Vascular | 9 | 2026 | 75 | 1.700 |
Why?
|
| Learning Curve | 4 | 2025 | 56 | 1.690 |
Why?
|
| Hospital Mortality | 20 | 2025 | 969 | 1.490 |
Why?
|
| Catheterization, Peripheral | 7 | 2025 | 125 | 1.480 |
Why?
|
| Mesenteric Arteries | 12 | 2024 | 50 | 1.470 |
Why?
|
| Celiac Artery | 9 | 2025 | 28 | 1.460 |
Why?
|
| Kaplan-Meier Estimate | 33 | 2020 | 1026 | 1.410 |
Why?
|
| Radiography, Interventional | 5 | 2025 | 83 | 1.360 |
Why?
|
| Vascular Grafting | 7 | 2021 | 47 | 1.350 |
Why?
|
| Minnesota | 34 | 2021 | 172 | 1.350 |
Why?
|
| Hematoma | 8 | 2022 | 84 | 1.320 |
Why?
|
| Chronic Disease | 23 | 2025 | 1179 | 1.300 |
Why?
|
| Feasibility Studies | 20 | 2025 | 789 | 1.290 |
Why?
|
| Embolization, Therapeutic | 11 | 2023 | 211 | 1.250 |
Why?
|
| Peripheral Arterial Disease | 11 | 2023 | 299 | 1.240 |
Why?
|
| Ulcer | 7 | 2021 | 48 | 1.230 |
Why?
|
| Models, Cardiovascular | 3 | 2026 | 172 | 1.220 |
Why?
|
| Carotid Stenosis | 8 | 2018 | 101 | 1.220 |
Why?
|
| Arterial Occlusive Diseases | 7 | 2021 | 96 | 1.170 |
Why?
|
| Surgeons | 2 | 2024 | 278 | 1.160 |
Why?
|
| Clinical Decision-Making | 5 | 2020 | 297 | 1.120 |
Why?
|
| Renal Artery Obstruction | 7 | 2022 | 38 | 1.120 |
Why?
|
| Electrosurgery | 2 | 2025 | 17 | 1.110 |
Why?
|
| Cone-Beam Computed Tomography | 4 | 2020 | 28 | 1.110 |
Why?
|
| Blood Loss, Surgical | 5 | 2020 | 168 | 1.110 |
Why?
|
| Clinical Competence | 3 | 2025 | 983 | 1.080 |
Why?
|
| Endarterectomy, Carotid | 8 | 2018 | 76 | 1.060 |
Why?
|
| Vascular System Injuries | 4 | 2025 | 54 | 1.050 |
Why?
|
| Aorta | 14 | 2025 | 503 | 1.050 |
Why?
|
| Pelvis | 4 | 2019 | 69 | 1.040 |
Why?
|
| Radiation Dosage | 3 | 2025 | 127 | 1.020 |
Why?
|
| Patient-Specific Modeling | 2 | 2026 | 10 | 1.020 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2022 | 746 | 1.010 |
Why?
|
| Retreatment | 14 | 2021 | 89 | 0.980 |
Why?
|
| Aneurysm, False | 4 | 2024 | 71 | 0.980 |
Why?
|
| Occupational Exposure | 2 | 2025 | 126 | 0.980 |
Why?
|
| Terminology as Topic | 3 | 2020 | 222 | 0.970 |
Why?
|
| United States | 49 | 2025 | 11187 | 0.960 |
Why?
|
| Glomerular Filtration Rate | 6 | 2021 | 494 | 0.950 |
Why?
|
| Occupational Health | 1 | 2025 | 46 | 0.900 |
Why?
|
| Printing, Three-Dimensional | 3 | 2022 | 81 | 0.880 |
Why?
|
| Lens, Crystalline | 1 | 2025 | 107 | 0.880 |
Why?
|
| Hemodynamics | 3 | 2026 | 800 | 0.860 |
Why?
|
| Subclavian Artery | 6 | 2022 | 66 | 0.850 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2024 | 66 | 0.850 |
Why?
|
| Brachial Artery | 3 | 2020 | 37 | 0.840 |
Why?
|
| Viscera | 4 | 2015 | 53 | 0.830 |
Why?
|
| Prosthesis-Related Infections | 5 | 2013 | 175 | 0.830 |
Why?
|
| Ehlers-Danlos Syndrome | 5 | 2019 | 48 | 0.830 |
Why?
|
| Acute Kidney Injury | 5 | 2023 | 601 | 0.820 |
Why?
|
| Drainage | 5 | 2025 | 251 | 0.820 |
Why?
|
| Arteries | 8 | 2023 | 196 | 0.810 |
Why?
|
| Loeys-Dietz Syndrome | 2 | 2023 | 40 | 0.800 |
Why?
|
| Databases, Factual | 17 | 2025 | 1171 | 0.790 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2022 | 47 | 0.790 |
Why?
|
| Infarction | 2 | 2020 | 19 | 0.770 |
Why?
|
| Length of Stay | 19 | 2024 | 1318 | 0.770 |
Why?
|
| Intracranial Aneurysm | 1 | 2023 | 77 | 0.760 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 505 | 0.760 |
Why?
|
| Incidence | 18 | 2025 | 3193 | 0.760 |
Why?
|
| Intraoperative Complications | 5 | 2023 | 155 | 0.750 |
Why?
|
| Prosthesis Failure | 11 | 2021 | 140 | 0.740 |
Why?
|
| Stroke | 10 | 2023 | 998 | 0.720 |
Why?
|
| Predictive Value of Tests | 20 | 2025 | 2176 | 0.720 |
Why?
|
| Vascular Access Devices | 5 | 2018 | 33 | 0.720 |
Why?
|
| Median Arcuate Ligament Syndrome | 2 | 2020 | 5 | 0.710 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 175 | 0.710 |
Why?
|
| Atherosclerosis | 8 | 2022 | 938 | 0.700 |
Why?
|
| Operative Time | 9 | 2021 | 193 | 0.670 |
Why?
|
| Adult | 64 | 2025 | 30314 | 0.660 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 80 | 0.650 |
Why?
|
| Solitary Kidney | 1 | 2020 | 2 | 0.650 |
Why?
|
| Catheterization | 3 | 2019 | 232 | 0.630 |
Why?
|
| Frailty | 1 | 2022 | 130 | 0.630 |
Why?
|
| Follow-Up Studies | 21 | 2020 | 5107 | 0.630 |
Why?
|
| Laparoscopy | 3 | 2020 | 516 | 0.630 |
Why?
|
| Embolism | 4 | 2018 | 43 | 0.620 |
Why?
|
| Embolic Protection Devices | 4 | 2018 | 8 | 0.610 |
Why?
|
| Catheters | 4 | 2020 | 81 | 0.610 |
Why?
|
| Registries | 16 | 2025 | 1478 | 0.610 |
Why?
|
| Kidney Diseases | 6 | 2021 | 469 | 0.610 |
Why?
|
| Endarterectomy | 5 | 2015 | 25 | 0.600 |
Why?
|
| Sarcopenia | 1 | 2019 | 54 | 0.600 |
Why?
|
| Publishing | 1 | 2020 | 104 | 0.590 |
Why?
|
| Blood Transfusion | 2 | 2020 | 285 | 0.590 |
Why?
|
| Metals | 2 | 2023 | 56 | 0.590 |
Why?
|
| Foot | 1 | 2019 | 61 | 0.590 |
Why?
|
| Thrombosis | 6 | 2019 | 497 | 0.590 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2025 | 202 | 0.580 |
Why?
|
| Mesentery | 5 | 2012 | 27 | 0.580 |
Why?
|
| Angiography | 12 | 2018 | 184 | 0.580 |
Why?
|
| Neurofibromatosis 1 | 2 | 2010 | 64 | 0.560 |
Why?
|
| Recurrence | 18 | 2020 | 1408 | 0.550 |
Why?
|
| Spinal Cord | 1 | 2018 | 244 | 0.530 |
Why?
|
| Paraplegia | 5 | 2022 | 75 | 0.530 |
Why?
|
| Physician's Role | 1 | 2018 | 160 | 0.520 |
Why?
|
| Carotid Artery Diseases | 3 | 2010 | 131 | 0.520 |
Why?
|
| Laparotomy | 1 | 2018 | 143 | 0.520 |
Why?
|
| Intermittent Claudication | 6 | 2021 | 52 | 0.510 |
Why?
|
| Constriction, Pathologic | 10 | 2020 | 223 | 0.500 |
Why?
|
| Survival Rate | 12 | 2020 | 2055 | 0.460 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 8 | 0.460 |
Why?
|
| Vascular Calcification | 2 | 2013 | 60 | 0.460 |
Why?
|
| Disease Progression | 13 | 2021 | 2110 | 0.460 |
Why?
|
| Lower Extremity | 5 | 2020 | 180 | 0.440 |
Why?
|
| Femoral Vein | 4 | 2020 | 49 | 0.440 |
Why?
|
| Thoracic Vertebrae | 1 | 2014 | 66 | 0.430 |
Why?
|
| Iliac Vein | 4 | 2012 | 28 | 0.430 |
Why?
|
| Spinal Fractures | 1 | 2014 | 43 | 0.430 |
Why?
|
| Chi-Square Distribution | 15 | 2016 | 541 | 0.430 |
Why?
|
| Models, Biological | 1 | 2019 | 1375 | 0.430 |
Why?
|
| Health Status Disparities | 4 | 2021 | 256 | 0.430 |
Why?
|
| Specialties, Surgical | 3 | 2020 | 88 | 0.430 |
Why?
|
| Vascular Fistula | 2 | 2012 | 27 | 0.430 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 103 | 0.420 |
Why?
|
| History, 21st Century | 4 | 2025 | 266 | 0.420 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 18 | 0.420 |
Why?
|
| Aortic Coarctation | 3 | 2022 | 96 | 0.420 |
Why?
|
| Disease-Free Survival | 9 | 2018 | 902 | 0.420 |
Why?
|
| Ischemic Attack, Transient | 4 | 2022 | 56 | 0.400 |
Why?
|
| Elective Surgical Procedures | 11 | 2021 | 141 | 0.400 |
Why?
|
| Renal Veins | 5 | 2015 | 33 | 0.400 |
Why?
|
| Societies, Medical | 4 | 2025 | 724 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2025 | 736 | 0.390 |
Why?
|
| Atherectomy | 1 | 2012 | 9 | 0.390 |
Why?
|
| History, 20th Century | 3 | 2025 | 368 | 0.380 |
Why?
|
| Collagen Type III | 3 | 2019 | 24 | 0.370 |
Why?
|
| Regional Blood Flow | 8 | 2019 | 197 | 0.360 |
Why?
|
| Evidence-Based Medicine | 7 | 2020 | 604 | 0.360 |
Why?
|
| Radiography | 6 | 2012 | 748 | 0.360 |
Why?
|
| Odds Ratio | 9 | 2020 | 1187 | 0.360 |
Why?
|
| Brazil | 3 | 2021 | 138 | 0.350 |
Why?
|
| Healthcare Disparities | 3 | 2021 | 479 | 0.350 |
Why?
|
| Hypertension | 3 | 2022 | 1281 | 0.350 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2018 | 121 | 0.350 |
Why?
|
| Punctures | 5 | 2025 | 60 | 0.350 |
Why?
|
| Venous Insufficiency | 2 | 2020 | 6 | 0.340 |
Why?
|
| Models, Anatomic | 2 | 2024 | 106 | 0.340 |
Why?
|
| Brachiocephalic Trunk | 1 | 2010 | 31 | 0.340 |
Why?
|
| Psoas Muscles | 2 | 2020 | 6 | 0.330 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 53 | 0.320 |
Why?
|
| Rifampin | 1 | 2011 | 119 | 0.320 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2015 | 7 | 0.320 |
Why?
|
| Renal Nutcracker Syndrome | 3 | 2015 | 5 | 0.320 |
Why?
|
| Watchful Waiting | 3 | 2021 | 72 | 0.320 |
Why?
|
| Acute Disease | 6 | 2024 | 1039 | 0.320 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 188 | 0.310 |
Why?
|
| Hypertension, Renovascular | 3 | 2022 | 28 | 0.310 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 2 | 2020 | 13 | 0.310 |
Why?
|
| Equipment Design | 5 | 2020 | 585 | 0.300 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 195 | 0.290 |
Why?
|
| Obesity | 1 | 2020 | 2328 | 0.290 |
Why?
|
| American Heart Association | 4 | 2023 | 306 | 0.290 |
Why?
|
| Carotid Arteries | 3 | 2020 | 129 | 0.290 |
Why?
|
| Aneurysm, Infected | 3 | 2004 | 21 | 0.290 |
Why?
|
| Young Adult | 20 | 2025 | 9635 | 0.290 |
Why?
|
| Survival Analysis | 5 | 2019 | 1475 | 0.290 |
Why?
|
| Heart Transplantation | 1 | 2015 | 858 | 0.290 |
Why?
|
| Syndrome | 3 | 2020 | 1114 | 0.280 |
Why?
|
| Varicose Veins | 2 | 2020 | 28 | 0.280 |
Why?
|
| Cardiology | 2 | 2023 | 472 | 0.270 |
Why?
|
| Carotid Artery, Common | 2 | 2011 | 58 | 0.270 |
Why?
|
| Multivariate Analysis | 10 | 2021 | 1349 | 0.270 |
Why?
|
| Polytetrafluoroethylene | 3 | 2015 | 62 | 0.270 |
Why?
|
| Proportional Hazards Models | 12 | 2018 | 1344 | 0.270 |
Why?
|
| Comorbidity | 9 | 2021 | 1525 | 0.270 |
Why?
|
| Veins | 4 | 2017 | 99 | 0.260 |
Why?
|
| Hemostatic Techniques | 2 | 2025 | 26 | 0.260 |
Why?
|
| Multicenter Studies as Topic | 3 | 2022 | 280 | 0.260 |
Why?
|
| Ultrasonography, Interventional | 3 | 2020 | 197 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2009 | 1179 | 0.260 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3658 | 0.260 |
Why?
|
| Asymptomatic Diseases | 5 | 2019 | 76 | 0.250 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 380 | 0.250 |
Why?
|
| Venous Thrombosis | 2 | 2010 | 167 | 0.250 |
Why?
|
| Aneurysm, Ruptured | 6 | 2015 | 30 | 0.250 |
Why?
|
| Abdomen | 2 | 2022 | 131 | 0.250 |
Why?
|
| Treatment Failure | 4 | 2020 | 335 | 0.250 |
Why?
|
| Mesenteric Veins | 2 | 2017 | 14 | 0.250 |
Why?
|
| Splanchnic Circulation | 4 | 2020 | 48 | 0.250 |
Why?
|
| Fluoroscopy | 2 | 2024 | 93 | 0.240 |
Why?
|
| Intestines | 1 | 2010 | 580 | 0.240 |
Why?
|
| Vascular Closure Devices | 1 | 2025 | 9 | 0.240 |
Why?
|
| Patient Discharge | 4 | 2023 | 461 | 0.230 |
Why?
|
| Device Removal | 4 | 2019 | 217 | 0.230 |
Why?
|
| Carotid Body Tumor | 2 | 2017 | 5 | 0.230 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2025 | 11 | 0.230 |
Why?
|
| Tibial Arteries | 1 | 2005 | 8 | 0.230 |
Why?
|
| Blood Flow Velocity | 2 | 2023 | 430 | 0.230 |
Why?
|
| Astronauts | 1 | 2025 | 38 | 0.230 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 111 | 0.230 |
Why?
|
| Aerospace Medicine | 1 | 2025 | 33 | 0.230 |
Why?
|
| Marfan Syndrome | 2 | 2023 | 124 | 0.220 |
Why?
|
| Vena Cava, Inferior | 3 | 2012 | 98 | 0.220 |
Why?
|
| Limb Salvage | 8 | 2020 | 140 | 0.220 |
Why?
|
| Prognosis | 7 | 2021 | 4697 | 0.220 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2015 | 67 | 0.220 |
Why?
|
| Wound Healing | 3 | 2025 | 445 | 0.210 |
Why?
|
| Intraoperative Care | 2 | 2020 | 118 | 0.210 |
Why?
|
| Clinical Protocols | 1 | 2025 | 224 | 0.210 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2024 | 260 | 0.210 |
Why?
|
| Fibromuscular Dysplasia | 2 | 2014 | 6 | 0.210 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 309 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2017 | 157 | 0.210 |
Why?
|
| Space Flight | 1 | 2025 | 98 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 4 | 2013 | 2509 | 0.210 |
Why?
|
| Hepatic Artery | 3 | 2016 | 46 | 0.210 |
Why?
|
| Severity of Illness Index | 7 | 2014 | 2926 | 0.210 |
Why?
|
| Editorial Policies | 1 | 2024 | 48 | 0.210 |
Why?
|
| Anastomosis, Surgical | 2 | 2019 | 159 | 0.210 |
Why?
|
| Iatrogenic Disease | 1 | 2004 | 122 | 0.200 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 30 | 0.200 |
Why?
|
| Anticoagulants | 3 | 2024 | 559 | 0.200 |
Why?
|
| Ankle Brachial Index | 3 | 2018 | 39 | 0.200 |
Why?
|
| Adolescent | 17 | 2024 | 19986 | 0.200 |
Why?
|
| Logistic Models | 11 | 2017 | 1739 | 0.200 |
Why?
|
| Collateral Circulation | 3 | 2018 | 40 | 0.200 |
Why?
|
| Computer Simulation | 1 | 2026 | 662 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2024 | 235 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 222 | 0.190 |
Why?
|
| Electroencephalography | 2 | 2020 | 845 | 0.190 |
Why?
|
| Hemorrhage | 1 | 2025 | 468 | 0.180 |
Why?
|
| Eye Diseases | 1 | 2002 | 80 | 0.180 |
Why?
|
| Endoscopy | 2 | 2018 | 281 | 0.180 |
Why?
|
| Foreign-Body Migration | 2 | 2013 | 57 | 0.180 |
Why?
|
| Cohort Studies | 8 | 2023 | 4894 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 2 | 2019 | 79 | 0.170 |
Why?
|
| Consensus | 1 | 2024 | 543 | 0.170 |
Why?
|
| Vascular Malformations | 2 | 2015 | 107 | 0.170 |
Why?
|
| Reperfusion | 1 | 2021 | 25 | 0.170 |
Why?
|
| Splenic Artery | 2 | 2022 | 21 | 0.170 |
Why?
|
| Surgical Flaps | 1 | 2002 | 190 | 0.170 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 418 | 0.170 |
Why?
|
| Quadriplegia | 1 | 2020 | 35 | 0.160 |
Why?
|
| Switzerland | 1 | 2020 | 14 | 0.160 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2020 | 14 | 0.160 |
Why?
|
| Tantalum | 1 | 2020 | 8 | 0.160 |
Why?
|
| Rupture, Spontaneous | 1 | 2020 | 43 | 0.160 |
Why?
|
| Polyvinyls | 1 | 2020 | 12 | 0.160 |
Why?
|
| Succinate Dehydrogenase | 1 | 2020 | 12 | 0.160 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2020 | 11 | 0.160 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2020 | 4 | 0.160 |
Why?
|
| Portal Vein | 2 | 2015 | 88 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2020 | 63 | 0.160 |
Why?
|
| Perfusion | 1 | 2021 | 192 | 0.160 |
Why?
|
| Replantation | 1 | 2020 | 46 | 0.160 |
Why?
|
| International Cooperation | 1 | 2020 | 156 | 0.160 |
Why?
|
| Cranial Nerve Injuries | 2 | 2017 | 5 | 0.160 |
Why?
|
| Sex Factors | 6 | 2021 | 1294 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2024 | 1385 | 0.150 |
Why?
|
| Thoracic Wall | 1 | 2019 | 40 | 0.150 |
Why?
|
| Pancreatectomy | 1 | 2020 | 144 | 0.150 |
Why?
|
| Neck | 1 | 2020 | 141 | 0.150 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2018 | 13 | 0.150 |
Why?
|
| Thrombectomy | 1 | 2020 | 105 | 0.150 |
Why?
|
| Mesenteric Cyst | 1 | 1998 | 2 | 0.150 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 140 | 0.150 |
Why?
|
| Frail Elderly | 1 | 2019 | 104 | 0.150 |
Why?
|
| Circle of Willis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Research | 1 | 2020 | 254 | 0.150 |
Why?
|
| Nephrectomy | 1 | 2020 | 172 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2012 | 1239 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 202 | 0.140 |
Why?
|
| Data Mining | 1 | 2018 | 58 | 0.140 |
Why?
|
| Renal Insufficiency | 2 | 2019 | 229 | 0.140 |
Why?
|
| Mutation | 3 | 2020 | 5933 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 135 | 0.140 |
Why?
|
| Preoperative Care | 3 | 2018 | 355 | 0.140 |
Why?
|
| Laser Therapy | 1 | 2020 | 240 | 0.140 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 903 | 0.140 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 92 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2018 | 83 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 79 | 0.140 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 39 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 474 | 0.140 |
Why?
|
| Body Composition | 1 | 2020 | 541 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 3593 | 0.140 |
Why?
|
| Patient Admission | 1 | 2018 | 165 | 0.140 |
Why?
|
| Peritoneovenous Shunt | 1 | 2017 | 5 | 0.130 |
Why?
|
| Chylous Ascites | 1 | 2017 | 10 | 0.130 |
Why?
|
| Middle Cerebral Artery | 1 | 2018 | 115 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 780 | 0.130 |
Why?
|
| Tomography, Spiral Computed | 1 | 2017 | 14 | 0.130 |
Why?
|
| Catheter Ablation | 1 | 2020 | 303 | 0.130 |
Why?
|
| Colon | 1 | 2020 | 354 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2021 | 191 | 0.130 |
Why?
|
| Streptococcal Infections | 2 | 2013 | 245 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 387 | 0.130 |
Why?
|
| Europe | 3 | 2025 | 353 | 0.130 |
Why?
|
| Health Status | 1 | 2018 | 376 | 0.130 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2015 | 15 | 0.120 |
Why?
|
| Duodenum | 1 | 2016 | 110 | 0.120 |
Why?
|
| Popliteal Vein | 1 | 2015 | 8 | 0.120 |
Why?
|
| Physicians | 1 | 2022 | 617 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 449 | 0.110 |
Why?
|
| Nerve Compression Syndromes | 1 | 2015 | 14 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 372 | 0.110 |
Why?
|
| Algorithms | 2 | 2018 | 1639 | 0.110 |
Why?
|
| Biomedical Engineering | 1 | 2015 | 24 | 0.110 |
Why?
|
| Axilla | 1 | 2015 | 38 | 0.110 |
Why?
|
| Motorcycles | 1 | 2014 | 8 | 0.110 |
Why?
|
| Constriction | 2 | 2013 | 43 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2018 | 770 | 0.110 |
Why?
|
| Fracture Fixation | 1 | 2014 | 28 | 0.110 |
Why?
|
| Radiology, Interventional | 1 | 2015 | 35 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 450 | 0.110 |
Why?
|
| Age Factors | 5 | 2021 | 2766 | 0.110 |
Why?
|
| Netherlands | 2 | 2024 | 45 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 530 | 0.110 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 560 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 587 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2019 | 50 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 950 | 0.110 |
Why?
|
| Athletic Injuries | 1 | 2015 | 61 | 0.110 |
Why?
|
| Writing | 1 | 2015 | 58 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2007 | 71 | 0.110 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 103 | 0.110 |
Why?
|
| Device Approval | 2 | 2014 | 12 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 709 | 0.110 |
Why?
|
| Awards and Prizes | 1 | 2015 | 64 | 0.110 |
Why?
|
| Stomach | 1 | 2016 | 265 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 218 | 0.100 |
Why?
|
| Phlebography | 4 | 2015 | 42 | 0.100 |
Why?
|
| Tennessee | 1 | 2013 | 34 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2013 | 72 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1125 | 0.100 |
Why?
|
| Living Donors | 1 | 2013 | 115 | 0.100 |
Why?
|
| Vascular Neoplasms | 1 | 2013 | 31 | 0.100 |
Why?
|
| Guanine | 2 | 2023 | 63 | 0.100 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 44 | 0.100 |
Why?
|
| Oximetry | 1 | 2013 | 174 | 0.090 |
Why?
|
| Ureteral Diseases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 527 | 0.090 |
Why?
|
| Urinary Fistula | 1 | 2012 | 19 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 902 | 0.090 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 16 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2013 | 104 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 258 | 0.090 |
Why?
|
| Arteriovenous Fistula | 1 | 2011 | 53 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2021 | 1164 | 0.090 |
Why?
|
| Tertiary Care Centers | 3 | 2017 | 245 | 0.090 |
Why?
|
| Spinal Cord Diseases | 1 | 2011 | 29 | 0.090 |
Why?
|
| Time | 1 | 2011 | 93 | 0.090 |
Why?
|
| Alloys | 1 | 2010 | 14 | 0.090 |
Why?
|
| Omentum | 1 | 2011 | 41 | 0.080 |
Why?
|
| Heart Arrest, Induced | 1 | 2011 | 69 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2011 | 122 | 0.080 |
Why?
|
| Dissection | 1 | 2011 | 58 | 0.080 |
Why?
|
| Survivors | 1 | 2013 | 344 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2016 | 673 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2877 | 0.080 |
Why?
|
| Neoplasms | 2 | 2017 | 2841 | 0.080 |
Why?
|
| Polyesters | 1 | 2009 | 34 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 154 | 0.080 |
Why?
|
| Cause of Death | 3 | 2018 | 469 | 0.080 |
Why?
|
| Vasculitis | 1 | 2010 | 45 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2011 | 136 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2013 | 1302 | 0.080 |
Why?
|
| Lymphatic Vessels | 1 | 2009 | 33 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 318 | 0.080 |
Why?
|
| Capillaries | 1 | 2009 | 69 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 445 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 398 | 0.070 |
Why?
|
| Dilatation, Pathologic | 2 | 2021 | 83 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2017 | 950 | 0.070 |
Why?
|
| Child | 7 | 2023 | 25112 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 556 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2020 | 422 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 723 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 41 | 0.070 |
Why?
|
| Hospitalization | 1 | 2016 | 1811 | 0.070 |
Why?
|
| Renal Dialysis | 3 | 2019 | 902 | 0.070 |
Why?
|
| Pregnancy | 3 | 2023 | 7395 | 0.070 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2019 | 44 | 0.060 |
Why?
|
| Rupture | 1 | 2005 | 32 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2005 | 0.060 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2025 | 19 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2011 | 3307 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2005 | 56 | 0.060 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 203 | 0.060 |
Why?
|
| Emergencies | 3 | 2014 | 172 | 0.060 |
Why?
|
| Genetic Counseling | 1 | 2006 | 236 | 0.060 |
Why?
|
| Hospitals, High-Volume | 2 | 2016 | 38 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2025 | 221 | 0.060 |
Why?
|
| Biomarkers | 3 | 2019 | 3149 | 0.060 |
Why?
|
| Listeriosis | 1 | 2004 | 20 | 0.050 |
Why?
|
| Research Design | 1 | 2008 | 687 | 0.050 |
Why?
|
| Salmonella Infections | 1 | 2004 | 31 | 0.050 |
Why?
|
| Leg | 1 | 2005 | 124 | 0.050 |
Why?
|
| Multidetector Computed Tomography | 2 | 2014 | 33 | 0.050 |
Why?
|
| Haemophilus Infections | 1 | 2004 | 97 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1107 | 0.050 |
Why?
|
| Thoracic Injuries | 1 | 2024 | 87 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 25 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 284 | 0.050 |
Why?
|
| Durable Medical Equipment | 1 | 2002 | 4 | 0.050 |
Why?
|
| Pectoralis Muscles | 1 | 2002 | 6 | 0.050 |
Why?
|
| Propensity Score | 2 | 2015 | 233 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2019 | 14375 | 0.050 |
Why?
|
| Aspirin | 1 | 2024 | 201 | 0.050 |
Why?
|
| Neck Dissection | 1 | 2002 | 29 | 0.050 |
Why?
|
| Research Report | 1 | 2022 | 69 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2004 | 184 | 0.050 |
Why?
|
| Universities | 1 | 2022 | 120 | 0.050 |
Why?
|
| North America | 1 | 2022 | 250 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 1823 | 0.050 |
Why?
|
| Diagnostic Imaging | 2 | 2015 | 278 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 537 | 0.040 |
Why?
|
| Aftercare | 1 | 2022 | 146 | 0.040 |
Why?
|
| Brachiocephalic Veins | 1 | 2000 | 13 | 0.040 |
Why?
|
| Subclavian Vein | 1 | 2000 | 21 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2024 | 1146 | 0.040 |
Why?
|
| Critical Illness | 2 | 2016 | 600 | 0.040 |
Why?
|
| Life Tables | 2 | 2016 | 24 | 0.040 |
Why?
|
| Prevalence | 1 | 2007 | 2571 | 0.040 |
Why?
|
| Heel | 1 | 2000 | 9 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 44 | 0.040 |
Why?
|
| Biopsy | 2 | 2015 | 1221 | 0.040 |
Why?
|
| Foot Ulcer | 1 | 2000 | 19 | 0.040 |
Why?
|
| Suction | 1 | 2020 | 50 | 0.040 |
Why?
|
| France | 1 | 2019 | 84 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 51 | 0.040 |
Why?
|
| Lung Diseases | 2 | 2017 | 392 | 0.040 |
Why?
|
| Troponin | 1 | 2019 | 55 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 355 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 300 | 0.040 |
Why?
|
| Italy | 1 | 2019 | 133 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2020 | 214 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 269 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 143 | 0.040 |
Why?
|
| Death Certificates | 1 | 2018 | 11 | 0.040 |
Why?
|
| Tobacco Use Disorder | 1 | 2019 | 88 | 0.040 |
Why?
|
| Poland | 1 | 2018 | 55 | 0.040 |
Why?
|
| Infant | 2 | 2019 | 12803 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 140 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 97 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2017 | 45 | 0.030 |
Why?
|
| Hong Kong | 1 | 2017 | 15 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2017 | 17 | 0.030 |
Why?
|
| Colombia | 1 | 2017 | 49 | 0.030 |
Why?
|
| Skull Base | 1 | 2017 | 46 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 282 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 192 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 226 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 230 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 898 | 0.030 |
Why?
|
| Ligation | 1 | 2016 | 136 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2015 | 34 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2015 | 34 | 0.030 |
Why?
|
| Liver Circulation | 1 | 2015 | 19 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2018 | 206 | 0.030 |
Why?
|
| Global Health | 1 | 2020 | 605 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 360 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 123 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 979 | 0.030 |
Why?
|
| Ohio | 1 | 2014 | 82 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 889 | 0.030 |
Why?
|
| Buttocks | 1 | 2014 | 5 | 0.030 |
Why?
|
| Colitis, Ischemic | 1 | 2014 | 2 | 0.030 |
Why?
|
| Physical Examination | 1 | 2015 | 160 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2014 | 58 | 0.030 |
Why?
|
| Second-Look Surgery | 1 | 2013 | 4 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 1233 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2013 | 29 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 119 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2013 | 134 | 0.030 |
Why?
|
| Pericardiectomy | 1 | 2013 | 10 | 0.020 |
Why?
|
| Renal Circulation | 1 | 2013 | 39 | 0.020 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2013 | 13 | 0.020 |
Why?
|
| Allografts | 1 | 2013 | 183 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 127 | 0.020 |
Why?
|
| Cardiac Tamponade | 1 | 2013 | 38 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2017 | 485 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 306 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2013 | 148 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 153 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 298 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1059 | 0.020 |
Why?
|
| Age Distribution | 1 | 2013 | 415 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2013 | 89 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 257 | 0.020 |
Why?
|
| Dyspnea | 1 | 2013 | 130 | 0.020 |
Why?
|
| Pericardium | 1 | 2013 | 101 | 0.020 |
Why?
|
| Cystoscopy | 1 | 2012 | 42 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 377 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 566 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2013 | 303 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 223 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 3895 | 0.020 |
Why?
|
| Heart Failure | 1 | 2023 | 2165 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 673 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2013 | 306 | 0.020 |
Why?
|
| Takayasu Arteritis | 1 | 2010 | 9 | 0.020 |
Why?
|
| Polyarteritis Nodosa | 1 | 2010 | 8 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2013 | 480 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2012 | 378 | 0.020 |
Why?
|
| Hypotension | 1 | 2011 | 177 | 0.020 |
Why?
|
| Giant Cell Arteritis | 1 | 2010 | 24 | 0.020 |
Why?
|
| Lymphography | 1 | 2009 | 11 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4313 | 0.020 |
Why?
|
| Sclerotherapy | 1 | 2009 | 38 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 2009 | 46 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 723 | 0.020 |
Why?
|
| Observation | 1 | 2009 | 31 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 503 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 612 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3260 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2038 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 918 | 0.020 |
Why?
|
| Groin | 1 | 2007 | 14 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2008 | 76 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2007 | 61 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 748 | 0.020 |
Why?
|
| Echocardiography | 1 | 2013 | 1097 | 0.020 |
Why?
|
| Warfarin | 1 | 2007 | 109 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1229 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 195 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 807 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 876 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1121 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 277 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1498 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 591 | 0.010 |
Why?
|
| Gangrene | 1 | 2000 | 27 | 0.010 |
Why?
|
| Debridement | 1 | 2000 | 88 | 0.010 |
Why?
|
| Graft Survival | 1 | 2000 | 453 | 0.010 |
Why?
|